2021 Advertising and Promotion for Medical Products Conference Agenda

Why Attend Agenda subject to change All times are in Eastern Daylight Time CLE Wednesday, October 13 10:55 – 11:10 AM Technology and Connection Support Session 11:15 – 11:30 AM FDLI Welcome and Introduction  Amy Comstock Rick, President & CEO, FDLI Madhavi Bellamkonda, Director, Regulatory Intelligence & Integration [...]

2021 Advertising and Promotion for Medical Products Conference Agenda2021-10-12T14:37:57-04:00

An Introduction to Biosimilar Product Regulation and Approval

An Introduction to Biosimilar Product Regulation and Approval Review background and definitions of biologic and biosimilar drugs and new drug application (NDAs) and biologics license application (BLAs). Discuss biosimilar pathways to market and application contents. Learn about the types of meetings available to interact with FDA. Examine interchangeability standards and conditions [...]

An Introduction to Biosimilar Product Regulation and Approval2022-04-04T10:53:00-04:00

Biologics License Applications (BLA): An Introduction

Biologics License Applications (BLA): An Introduction Assess historical and current standards of approval. Discuss what standard FDA uses to approve a BLA submitted under section 351(a) of the Public Health Service Act (PHSA). Outline what is in section 351(a) BLA. Understand FDA’s review and decision processes. Andrew Papas , Vice President of [...]

Biologics License Applications (BLA): An Introduction2022-04-04T10:53:20-04:00

Regenerative Medicine and Advanced Therapies: An Introduction

Regenerative Medicine and Advanced Therapies: An Introduction Distinguish between human cellular and tissue-based products (HCT/P). Review the regulatory framework for the regulation of regenerative medicine products and discuss key definitions and eligible therapies. Examine expedited programs for RMATs. Review emerging issues in gene editing, in-office procedures and stem cell manufacturing practices. [...]

Regenerative Medicine and Advanced Therapies: An Introduction2022-04-04T10:51:35-04:00

2021 Food Advertising, Labeling, and Litigation Conference Agenda

Why Attend Agenda All times are in Eastern Daylight Time CLE Monday, September 27 3:15–3:30 PM Welcome and Keynote Introduction Amy Comstock Rick, President & CEO, FDLI 3:30–4:10 PM Keynote Address Claudine Kavanaugh, Director, Office of Nutrition and Food Labeling, Center for Food Safety and Applied Nutrition (CFSAN), [...]

2021 Food Advertising, Labeling, and Litigation Conference Agenda2021-09-21T16:01:48-04:00

Top Food and Drug Cases, 2020, & Cases to Watch, 2021

Top Food and Drug Cases, 2020, & Cases to Watch, 2021 FDLI’s Top Food and Drug Cases is the companion volume to the popular panel at our Annual Conference. Become A Member As a general matter, “looking back at 2020” is a singularly unpleasant prospect for the vast majority [...]

Top Food and Drug Cases, 2020, & Cases to Watch, 20212022-06-30T14:08:18-04:00

AMG Capital Management, LLC v. Federal Trade Commission

AMG Capital Management, LLC v. Federal Trade Commission T. DANIEL LOGAN & JAQUELINE J. CHAN* Why It Made the List On first glance, a case about the Federal Trade Commission’s (FTC’s) remedies against payday lending may not appear relevant to food and drug law and its practitioners. However, in effect, many agencies pull enforcement [...]

AMG Capital Management, LLC v. Federal Trade Commission2022-06-29T11:13:00-04:00
Go to Top